Classification
Product TypeProcessed Food
Product FormRetail packaged food supplement (liquid oil / powder)
Industry PositionConsumer Packaged Supplement Product
Market
MCT supplements in Great Britain (GB) are sold as food supplements (a form of food) rather than medicines, and are commonly marketed as coconut-derived MCT oils or MCT powders for use in drinks and foods. GB labelling and marketing must comply with food-supplement rules, including presenting the product as a “food supplement” and avoiding disease-treatment claims that could trigger medicines enforcement. Nutrition and health claims used in commercial communications must be authorised for GB and aligned to the Great Britain nutrition and health claims register. Consumer purchasing is strongly oriented to health retailers and e-commerce, where the FSA highlights elevated risks around counterfeit or non-compliant products on online marketplaces.
Market RoleImport-dependent consumer market (raw MCT inputs are typically coconut/palm-kernel derived) with domestic retail distribution and some UK-based packing/bottling
Domestic RoleRetail food-supplement category positioned around lifestyle nutrition (e.g., keto/low-carb) and general wellness channels
Risks
Regulatory Compliance HighMedicines-borderline enforcement risk: if an MCT supplement is marketed with claims to prevent, treat or cure disease (or otherwise presented as medicinal), it may be treated as a medicine and face takedown, trading standards action, or MHRA scrutiny, disrupting GB market access.Run a pre-launch claims audit against GB food-supplement and GB NHC-register requirements; obtain MHRA borderline advice when claims or presentation could be interpreted as medicinal.
Counterfeit And Illicit Trade MediumOnline marketplace exposure increases the risk of counterfeit, non-compliant labelling, or misleading claims for supplements, creating brand and compliance risk in GB.Prioritise authorised sellers, monitor listings, and keep robust traceability and complaint-handling workflows aligned to FSA guidance.
Sustainability MediumUpstream land-use risk where palm-kernel-derived inputs are used; sustainability scrutiny can affect buyer acceptance and reputational standing for MCT products positioned as ‘clean’ or ‘ethical’.Implement supplier mapping and due diligence on origin and land-use legality; ensure sustainability claims are evidence-backed and consistent with legal and retailer requirements.
Regulatory Divergence MediumGB vs Northern Ireland (NI) rules and labelling address requirements can create compliance complexity for businesses selling UK-wide, increasing risk of mislabelling or restricted distribution to NI.Define GB-only vs UK-wide SKU strategy early; validate label address requirements and claims regime applicability for NI separately.
Logistics LowFreight-rate volatility can affect landed costs for imported oils and finished supplements, especially for heavier liquid formats.Diversify suppliers and formats where feasible; use freight contracts and inventory buffers for high-volume SKUs.
Sustainability- Palm-kernel-derived MCT (where used) carries deforestation and biodiversity-risk scrutiny in global supply chains; GB operators may face increasing due-diligence expectations for forest-risk commodities.
- Sustainability claims such as “no palm oil” or “deforestation-free” require careful substantiation to avoid greenwashing risk.
- Certification reliance is contested: RSPO is widely used by industry, but some NGOs criticise RSPO as insufficient to guarantee deforestation-free palm supply chains.
Labor & Social- Modern Slavery Act (transparency in supply chains) expectations can extend to commodity supply chains relevant to supplement ingredients and packaging materials for in-scope organisations.
- Coconut sourcing has faced animal-welfare controversy in Thailand (allegations of forced monkey labour in coconut harvesting); GB importers/brands using coconut-derived inputs may face reputational and buyer due-diligence scrutiny depending on origin and supplier controls.
Standards- BRCGS Global Standard Food Safety (commonly used supplier assurance framework in food supply chains)
- HACCP-based food safety management (commonly expected for food manufacturing/packing controls)
FAQ
Can an MCT supplement in Great Britain be marketed as treating or preventing a medical condition?No. In Great Britain, food supplements are not medicinal products and should not be sold with claims that they can prevent, treat or cure a medical condition. If a product is presented with medicinal claims, it may be treated as a medicine and can face enforcement action.
Where can I verify whether a nutrition or health claim is permitted for use on an MCT supplement in Great Britain?Check the Great Britain nutrition and health claims (NHC) register. Only authorised claims in that register may be used in commercial communications in Great Britain, and claims must be used under their conditions of use.
What are some key label expectations for food supplements sold in Great Britain, and what changes if selling into Northern Ireland?Food supplements in Great Britain are expected to be labelled as “food supplement” (not “dietary supplement”) and include an ingredient list (with allergens emphasised), usage conditions and dosage warnings, storage instructions, and the relevant business name/address. If selling into Northern Ireland, additional address requirements can apply (NI or EU address for the food business, or an NI/EU importer address if the business is outside NI/EU).